Mark Prausnitz, a Georgia Tech Regents professor in the School of Chemical and Biomolecular Engineering, holds a microneedle vaccine patch containing needles that dissolve into the skin.
Stories this photo appears in:
Skin Patch May Be the Future of Flu Vaccines, Study Suggests
The future of flu vaccines just might come in a tiny, prickly patch. A phase 1 clinical trial, the results of which were published in the medical journal Lancet on Tuesday, has deemed the dissolvable microneedle flu patch to be "well tolerated" and safe for possible use.
